189 related articles for article (PubMed ID: 16375887)
1. Characterisation of CGRP receptors in human and porcine isolated coronary arteries: evidence for CGRP receptor heterogeneity.
Gupta S; Mehrotra S; Villalón CM; Garrelds IM; de Vries R; van Kats JP; Sharma HS; Saxena PR; Maassenvandenbrink A
Eur J Pharmacol; 2006 Jan; 530(1-2):107-16. PubMed ID: 16375887
[TBL] [Abstract][Full Text] [Related]
2. Characterisation of CGRP receptors in the human isolated middle meningeal artery.
Gupta S; Mehrotra S; Avezaat CJ; Villalón CM; Saxena PR; Maassenvandenbrink A
Life Sci; 2006 Jun; 79(3):265-71. PubMed ID: 16458930
[TBL] [Abstract][Full Text] [Related]
3. Limitations in using peptide drugs to characterize calcitonin gene-related peptide receptors.
Waugh DJ; Bockman CS; Smith DD; Abel PW
J Pharmacol Exp Ther; 1999 Jun; 289(3):1419-26. PubMed ID: 10336535
[TBL] [Abstract][Full Text] [Related]
4. Investigation of CGRP receptors and peptide pharmacology in human coronary arteries. Characterization with a nonpeptide antagonist.
Hasbak P; Saetrum Opgaard O; Eskesen K; Schifter S; Arendrup H; Longmore J; Edvinsson L
J Pharmacol Exp Ther; 2003 Jan; 304(1):326-33. PubMed ID: 12490608
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological characterisation of capsaicin-induced relaxations in human and porcine isolated arteries.
Gupta S; Lozano-Cuenca J; Villalón CM; de Vries R; Garrelds IM; Avezaat CJ; van Kats JP; Saxena PR; MaassenVanDenBrink A
Naunyn Schmiedebergs Arch Pharmacol; 2007 Mar; 375(1):29-38. PubMed ID: 17295025
[TBL] [Abstract][Full Text] [Related]
6. CGRP receptors mediating CGRP-, adrenomedullin- and amylin-induced relaxation in porcine coronary arteries. Characterization with 'Compound 1' (WO98/11128), a non-peptide antagonist.
Hasbak P; Sams A; Schifter S; Longmore J; Edvinsson L
Br J Pharmacol; 2001 Aug; 133(8):1405-13. PubMed ID: 11498528
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of the non-peptide CGRP receptor antagonist BIBN4096BS in blocking CGRP-induced dilations in human and bovine cerebral arteries: potential implications in acute migraine treatment.
Moreno MJ; Abounader R; Hébert E; Doods H; Hamel E
Neuropharmacology; 2002 Mar; 42(4):568-76. PubMed ID: 11955527
[TBL] [Abstract][Full Text] [Related]
8. Characterization of calcitonin gene-related peptide (CGRP) receptors in intramural coronary arteries from male and female Sprague Dawley rats.
Sheykhzade M; Nyborg NC
Br J Pharmacol; 1998 Apr; 123(7):1464-70. PubMed ID: 9579744
[TBL] [Abstract][Full Text] [Related]
9. Increased alphaCGRP potency and CGRP-receptor antagonist affinity in isolated hypoxic porcine intramyocardial arteries.
Hasbak P; Eskesen K; Schifter S; Edvinsson L
Br J Pharmacol; 2005 Jul; 145(5):646-55. PubMed ID: 15834440
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effect of BIBN4096BS, CGRP(8-37), a CGRP antibody and an RNA-Spiegelmer on CGRP induced vasodilatation in the perfused and non-perfused rat middle cerebral artery.
Edvinsson L; Nilsson E; Jansen-Olesen I
Br J Pharmacol; 2007 Mar; 150(5):633-40. PubMed ID: 17245362
[TBL] [Abstract][Full Text] [Related]
11. Functional calcitonin gene-related peptide subtype 2 receptors in porcine coronary arteries are identified as calcitonin gene-related peptide subtype 1 receptors by radioligand binding and reverse transcription-polymerase chain reaction.
Rorabaugh BR; Scofield MA; Smith DD; Jeffries WB; Abel PW
J Pharmacol Exp Ther; 2001 Dec; 299(3):1086-94. PubMed ID: 11714898
[TBL] [Abstract][Full Text] [Related]
12. Potentiated adrenomedullin-induced vasorelaxation during hypoxia in organ cultured porcine coronary arteries.
Hasbak P; Sheykhzade M; Schifter S; Edvinsson L
J Cardiovasc Pharmacol; 2014 Jan; 63(1):58-67. PubMed ID: 24084221
[TBL] [Abstract][Full Text] [Related]
13. Characterization of calcitonin gene-related peptide (CGRP) receptors and their receptor-activity-modifying proteins (RAMPs) in human brain microvascular and astroglial cells in culture.
Moreno MJ; Terrón JA; Stanimirovic DB; Doods H; Hamel E
Neuropharmacology; 2002 Feb; 42(2):270-80. PubMed ID: 11804624
[TBL] [Abstract][Full Text] [Related]
14. Receptors mediating CGRP-induced relaxation in the rat isolated thoracic aorta and porcine isolated coronary artery differentiated by h(alpha) CGRP(8-37).
Wisskirchen FM; Gray DW; Marshall I
Br J Pharmacol; 1999 Sep; 128(2):283-92. PubMed ID: 10510437
[TBL] [Abstract][Full Text] [Related]
15. Noncompetitive antagonism of BIBN4096BS on CGRP-induced responses in human subcutaneous arteries.
Sheykhzade M; Lind H; Edvinsson L
Br J Pharmacol; 2004 Dec; 143(8):1066-73. PubMed ID: 15477223
[TBL] [Abstract][Full Text] [Related]
16. Development and potential of non-peptide antagonists for calcitonin-gene-related peptide (CGRP) receptors: evidence for CGRP receptor heterogeneity.
Wu D; Doods H; Arndt K; Schindler M
Biochem Soc Trans; 2002 Aug; 30(4):468-73. PubMed ID: 12196117
[TBL] [Abstract][Full Text] [Related]
17. Effect of the CGRP receptor antagonist BIBN4096BS in human cerebral, coronary and omental arteries and in SK-N-MC cells.
Edvinsson L; Alm R; Shaw D; Rutledge RZ; Koblan KS; Longmore J; Kane SA
Eur J Pharmacol; 2002 Jan; 434(1-2):49-53. PubMed ID: 11755165
[TBL] [Abstract][Full Text] [Related]
18. Production of cAMP by adrenomedullin in human oligodendroglial cell line KG1C: comparison with calcitonin gene-related peptide and amylin.
Uezono Y; Nakamura E; Ueda Y; Shibuya I; Ueta Y; Yokoo H; Yanagita T; Toyohira Y; Kobayashi H; Yanagihara N; Wada A
Brain Res Mol Brain Res; 2001 Dec; 97(1):59-69. PubMed ID: 11744163
[TBL] [Abstract][Full Text] [Related]
19. CGRP and adrenomedullin receptor populations in human cerebral arteries: in vitro pharmacological and molecular investigations in different artery sizes.
Sams A; Knyihár-Csillik E; Engberg J; Szok D; Tajti J; Bodi I; Edvinsson L; Vécsei L; Jansen-Olesen I
Eur J Pharmacol; 2000 Nov; 408(2):183-93. PubMed ID: 11080525
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the calcitonin gene-related peptide receptor antagonist telcagepant (MK-0974) in human isolated coronary arteries.
Chan KY; Edvinsson L; Eftekhari S; Kimblad PO; Kane SA; Lynch J; Hargreaves RJ; de Vries R; Garrelds IM; van den Bogaerdt AJ; Danser AH; Maassenvandenbrink A
J Pharmacol Exp Ther; 2010 Sep; 334(3):746-52. PubMed ID: 20573757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
